US 11,667,607 B1
Crystalline forms of compositions comprising psilocin and psilocybin
Peter Silverstone, Calgary (CA)
Assigned to Zylorion Health Inc., Calgary (CA)
Filed by ZYLORION HEALTH INC., Calgary (CA)
Filed on Sep. 12, 2022, as Appl. No. 17/942,706.
Claims priority of provisional application 63/357,450, filed on Jun. 30, 2022.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 209/16 (2006.01)
CPC C07D 209/16 (2013.01) [C07B 2200/13 (2013.01)] 22 Claims
 
1. A composition comprising a crystalline form of psilocin and psilocybin:

OG Complex Work Unit Chemistry
wherein the crystalline form is crystalline Form A; and
wherein crystalline Form A is characterized by a XRPD patter comprising a peak at a 2θ angle of 10.1°, 19.16°, 14.54°, 16.5°, 13.44°, 23.42°, and 8.62.